(Q85995735)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Statin use and incident prostate cancer risk: does the statin brand matter? A population-based cohort study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061633%20AND%20SRC:MED&resulttype=core&format=json

population-based cohort study

22 February 2020

main subject

1 reference

1 reference

A Lustman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

S Nakar

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

A D Cohen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

S Vinker

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

24 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061633%20AND%20SRC:MED&resulttype=core&format=json

Prostate Cancer and Prostatic Diseases

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061633%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

6-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24061633%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/pcan.2013.34

22 February 2020

exact match

0 references

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

Statins and prostate cancer prevention: where we are now, and future directions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

Statin use and risk of prostate cancer: results from a population-based epidemiologic study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

Statin drugs and risk of advanced prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

Statins and prostate cancer risk: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

Statin use and risk of prostate cancer in the California Men's Health Study cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

The Risk of Cancer in Users of Statins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

Long-term follow-up of the West of Scotland Coronary Prevention Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

Statins and the risk of colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

Statins do not decrease the risk for wet age-related macular degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

Topical beta-blockers are not associated with an increased risk of treatment for depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

Statin administration and risk of cholecystectomy: a population-based case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34

Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2013.34